The OncoVector Podcast: Mike Kujak w/Franics Medical

In this episode of the OncoVector Podcast, I sit down with Mike Kujak of Francis Medical to discuss the evolving landscape of prostate cancer detection and treatment, and how new approaches are helping us become more precise at both ends of the patient journey. We explore the importance of early and accurate detection, the role this plays in determining the right treatment pathway, and the growing potential of focal therapy for patients with localised prostate cancer. A key theme throughout our conversation is precision. As our ability to identify clinically significant disease improves, so does the opportunity to move away from unnecessarily broad treatment and towards approaches that target the cancer while preserving healthy tissue and, importantly, quality of life. Mike also shares his perspective on the work being done at Francis Medical, the development of minimally invasive technologies for prostate cancer, and where he sees the field heading. We cover: • Why early detection remains so important in prostate cancer • The challenges of accurately identifying clinically significant disease • The growing role of focal therapy • Balancing oncological control with quality of life • The importance of minimising treatment-related side effects • Innovation in minimally invasive prostate cancer treatment • Where the prostate cancer treatment landscape could go next A fascinating conversation with Mike and one I’m very pleased to share. If you work in oncology, medtech, diagnostics, urology or cancer research, I’d love to hear your thoughts in the comments. About OncoVector The OncoVector Podcast brings together leaders and innovators from across oncology to discuss the science, technology and ideas shaping the future of cancer detection and treatment. #ProstateCancer #Oncology #FocalTherapy #MedTech #CancerResearch #Urology #OncoVector